COVID-19

lymphoma

What Lymphoma Patients Need to Know About Current Treatments for COVID-19

As of mid-2022, there are a number of treatments for COVID-19 that have been either approved by the FDA or have been authorized for emergency use (EUA).

lymphoma

What Lymphoma Patients Need to Know About the Approved Preventative COVID-19 Antibody

On December 8, 2021, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for AstraZeneca’s Evusheld, a monoclonal antibody combination of tixagevimab and cilgavimab.

lymphoma

Update Recommendations for Booster Shots

Recommended questions lymphoma patients, survivors, and caregivers can ask their healthcare provider.

lymphoma

COVID-19 Vaccine Updates and FAQs

The Lymphoma Research Foundation (LRF) encourages patients, survivors, and their caregivers to take information and questions back to their individual health care providers as a way of creating a dialogue and partnership about their lymphoma and treatment.

CDC Updates COVID-19 Vaccine Recommendations for Moderately to Severely Immunocompromised People

People who have compromised immune systems may benefit from an additional dose to make sure they have enough protection against COVID-19.

CDC Updates COVID-19 Vaccine Guidance for Immunocompromised

On July 27, 2021, the Centers for Disease Control and Prevention (CDC) updated its Guidance for Fully Vaccinated people to include recommendations for those in the same household as immunocompromised people, including those with blood cancer.

Patient Perspectives: Understanding Telemedicine

With telemedicine trending to be a mainstay in how healthcare professionals treat patients, Ameet Doshi, MD, MBA, Lead Hospitalist for Telemedicine at HealthPartners, shares what is contributing to the surge and how it affects lymphoma patients and survivors.